Briefing Session for Influenza Vaccine Manufacturers and Importers

The Ministry of Food and Drug Safety announced that it will hold a briefing session on June 12 to assist influenza vaccine manufacturers and importers in preparing for national batch release approval. This is to ensure the smooth supply of flu vaccines in the second half of this year and to enable the public to receive vaccinations at the appropriate time.


During this briefing session, the following topics will be addressed: ▲ Procedures and methods for national batch release approval ▲ The 2026 national batch release plan for flu vaccines ▲ Precautions when preparing the manufacturing and quality management summary ▲ The 2026 national immunization flu vaccine supply and procurement plan (from the Korea Disease Control and Prevention Agency).

MFDS Preparing for National Batch Release Approval of 27.4 Million Flu Vaccine Doses This Year View original image

This year, approximately 27.4 million doses of flu vaccine are expected to receive national batch release approval. This includes eight domestically manufactured products and six imported products. As in the previous year, the trivalent flu vaccine, which mainly consists of two types of A strains (H1N1 and H3N2) and one type of B strain (Victoria), adopted in accordance with World Health Organization (WHO) recommendations, is expected to be mainly supplied this year.



The Ministry stated, "We expect that this briefing session will help the public receive flu vaccinations smoothly during the recommended vaccination period (October to November)," adding, "We will continue to do our best to maintain vaccine quality management based on our expertise in testing and inspection."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing